This topic contains a solution. Click here to go to the answer

Author Question: While preparing a patient about to undergo percutaneous umbilical cord blood sampling, which of the ... (Read 110 times)

corkyiscool3328

  • Hero Member
  • *****
  • Posts: 539
While preparing a patient about to undergo percutaneous umbilical cord blood sampling, which of the following information should the nurse provide as preprocedure teaching?
 
  Select all that apply.
  A)
  Once the procedure is begun, you must lie very still since they will be inserting a needle through the uterine wall.
  B)
  We will put you into the stirrups and dilate your cervix with a small catheter so that we can obtain a cord sample.
  C)
  During the procedure, an ultrasound will be utilized to guide the catheter into the correct position.
  D)
  We will send a sample of amniotic fluid to a regional medical center to have DNA tests performed for any genetic abnormality.

Question 2

While the nurse is educating a fellow nurse about some new research being developed to treat hepatitis C, specifically to identify disease-related drug targets on the cells, the nurse will be basing these data on which new technology finding?
 
  A)
  Recombinant DNA technology
  B)
  Haplotype mapping
  C)
  The human genome project
  D)
  Interference RNA (RNAi)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

CharlieArnold

  • Sr. Member
  • ****
  • Posts: 319
Answer to Question 1

Ans:
A, C

Feedback:

PUBS is an invasive diagnostic procedure that involves the transcutaneous insertion of a needle through the uterine wall and into the umbilical artery. It is performed under ultrasound guidance and can be done any time after 16 weeks of gestation. Amniocentesis is the withdrawal of a sample of amniotic fluid for abnormal fetal screening as well as for chromosomal analysis. In chorionic villus sampling, the transcervical approach may be used (answer B).

Answer to Question 2

Ans:
D

Feedback:

Pharmaceutical companies are using RNAi to identify disease-related drug targets. There is considerable interest in harnessing RNAi for therapeutic purposes, linking the treatment of HIV infection and hepatitis C.




corkyiscool3328

  • Member
  • Posts: 539
Reply 2 on: Jun 25, 2018
Thanks for the timely response, appreciate it


tandmlomax84

  • Member
  • Posts: 323
Reply 3 on: Yesterday
Excellent

 

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

The first-known contraceptive was crocodile dung, used in Egypt in 2000 BC. Condoms were also reportedly used, made of animal bladders or intestines.

Did you know?

A headache when you wake up in the morning is indicative of sinusitis. Other symptoms of sinusitis can include fever, weakness, tiredness, a cough that may be more severe at night, and a runny nose or nasal congestion.

Did you know?

Egg cells are about the size of a grain of sand. They are formed inside of a female's ovaries before she is even born.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

For a complete list of videos, visit our video library